Peptide Education Manager
Edit Ipamorelin
Name
Scientific / Common Name
Alternative Names
Slug (url-safe, unique)
Short Description (shown on cards)
A selective growth hormone secretagogue studied for its potential role in supporting the body's natural growth hormone pulses.
Overview — What Is It? (paragraphs)
Ipamorelin is a peptide that acts on the ghrelin receptor pathway, which is involved in triggering growth hormone release from the pituitary gland. It is often described in research literature as more selective than some older growth hormone secretagogues, meaning it has been studied for primarily stimulating growth hormone without strongly affecting other hormones like cortisol. Ipamorelin has been studied in early-phase human pharmacology research as well as in animal models, with researchers examining its effects on growth hormone secretion patterns. It is frequently discussed alongside other growth hormone pathway peptides, either on its own or in combination formulations.
Why Being Studied (one item per line)
Selective growth hormone receptor stimulation Sleep quality and recovery Lean body composition Fat metabolism signaling
How It May Work
Ipamorelin is proposed to mimic ghrelin and bind to the growth hormone secretagogue receptor, stimulating a pulse of growth hormone release from the pituitary gland. Researchers have studied this pathway for its downstream relationship to metabolism, sleep, and tissue recovery.
Mechanism Pathway Steps (one per line)
Ipamorelin Ghrelin receptor (growth hormone secretagogue receptor) Pituitary growth hormone pulse release Downstream metabolic & recovery effects under study
Evidence Rating
Established / Approved Use
Strong Human Evidence
Moderate Human Evidence
Early Human Evidence
Preclinical Evidence
Emerging / Limited Evidence
Human Evidence
Small early-phase human pharmacology studies have examined Ipamorelin's effects on growth hormone secretion patterns. Large-scale, long-term clinical trial data in humans is limited.
Preclinical Evidence
Animal studies have characterized Ipamorelin's receptor selectivity and growth hormone-releasing activity.
What We Don't Know Yet
Long-term safety data, optimal dosing for wellness applications, and effects with extended use in humans have not been fully established.
Research Area Cards (format: Title: description — one per line)
Muscle & Body Composition: Growth hormone pathway activity has been linked to lean mass and fat metabolism in research models. Sleep: Growth hormone release is tied to deep sleep stages, making this a research area of interest. Performance: Some research has explored growth hormone secretagogues in relation to recovery and physical performance.
Why Might Someone Discuss This With Their Provider?
Someone interested in growth hormone pathway research, recovery, or body composition may encounter Ipamorelin while exploring secretagogue peptides.
Regulatory Status
Ipamorelin is not approved by the FDA for any indication and is not an FDA-approved drug product.
Important Considerations
Growth hormone secretagogues can influence other hormone systems. Available human evidence is early-stage. Discuss any interest in this pathway with a licensed healthcare provider.
Related Peptide Slugs (one per line)
cjc-1295-ipamorelin sermorelin tesamorelin
Is Combination Product?
Categories / Goals
Recovery & Repair
Metabolic Health
Weight Management
Performance
Muscle & Body Composition
Sleep & Recovery
Cognitive Health
Stress & Mood
Longevity & Healthy Aging
Cellular Energy
Skin, Hair & Aesthetics
Sexual Wellness
Search Tags (comma separated)
Last Reviewed Date
Display Order
Published
Featured
Save Peptide